Agilent Technologies Inc. and Synthego Corp. sparred Friday over whether Agilent patents related to a key component of the ...
The sequence contained a promising new genetic tool for modifying DNA, a CRISPR. Editas Medicine, a Massachusetts-based ...
European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948) to CVC, with broad claims covering guide RNAs and their combination with Cas9. Patent strengthens CVC's leading position in ...
EPO grants new CRISPR/Cas9 patent to CVC, with broad claims covering guide RNAs and their combination with Cas9: Dublin, Ireland Friday, February 28, 2025, 14:00 Hrs [IST] ERS Gen ...
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...
This is exemplified by granted US patent US11,517,582, which covers the use of CRISPR-Cas systems to achieve selective killing of bacteria by at least 1000-fold in situations where bacteria are ...
CRISPR libraries enable scientists to systematically investigate gene functions, identify novel drug targets, and develop personalized therapies.
Patent strengthens CVC's leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback